PL3117012T5 - Sposoby monitorowania terapii immunosupresyjnych u biorcy przeszczepu - Google Patents

Sposoby monitorowania terapii immunosupresyjnych u biorcy przeszczepu

Info

Publication number
PL3117012T5
PL3117012T5 PL15761889.3T PL15761889T PL3117012T5 PL 3117012 T5 PL3117012 T5 PL 3117012T5 PL 15761889 T PL15761889 T PL 15761889T PL 3117012 T5 PL3117012 T5 PL 3117012T5
Authority
PL
Poland
Prior art keywords
methods
transplant recipients
immunosuppressive therapies
monitoring
monitoring immunosuppressive
Prior art date
Application number
PL15761889.3T
Other languages
English (en)
Other versions
PL3117012T3 (pl
Inventor
Robert Woodward
Marica Grskovic
Jim Yee
Mitch NELLES
David HILLER
Original Assignee
Caredx, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54072508&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3117012(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Caredx, Inc. filed Critical Caredx, Inc.
Publication of PL3117012T3 publication Critical patent/PL3117012T3/pl
Publication of PL3117012T5 publication Critical patent/PL3117012T5/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL15761889.3T 2014-03-14 2015-03-13 Sposoby monitorowania terapii immunosupresyjnych u biorcy przeszczepu PL3117012T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461953582P 2014-03-14 2014-03-14
EP15761889.3A EP3117012B2 (en) 2014-03-14 2015-03-13 Methods of monitoring immunosuppressive therapies in a transplant recipient
PCT/US2015/020603 WO2015138997A1 (en) 2014-03-14 2015-03-13 Methods of monitoring immunosuppressive therapies in a transplant recipient

Publications (2)

Publication Number Publication Date
PL3117012T3 PL3117012T3 (pl) 2019-08-30
PL3117012T5 true PL3117012T5 (pl) 2026-03-16

Family

ID=54072508

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15761889.3T PL3117012T5 (pl) 2014-03-14 2015-03-13 Sposoby monitorowania terapii immunosupresyjnych u biorcy przeszczepu

Country Status (16)

Country Link
US (12) US11767559B2 (pl)
EP (1) EP3117012B2 (pl)
CN (2) CN113528645A (pl)
AU (3) AU2015229083B2 (pl)
BR (1) BR112016021038B1 (pl)
CA (1) CA2970916C (pl)
DK (1) DK3117012T4 (pl)
ES (1) ES2726650T5 (pl)
FI (1) FI3117012T4 (pl)
HR (1) HRP20190759T4 (pl)
HU (1) HUE043288T2 (pl)
PL (1) PL3117012T5 (pl)
PT (1) PT3117012T (pl)
SI (1) SI3117012T2 (pl)
TR (1) TR201907106T4 (pl)
WO (1) WO2015138997A1 (pl)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
ES2640776T3 (es) 2009-09-30 2017-11-06 Natera, Inc. Métodos para denominar de forma no invasiva ploidía prenatal
US12655483B2 (en) 2010-05-18 2026-06-16 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11339429B2 (en) * 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
EP2854058A3 (en) 2010-05-18 2015-10-28 Natera, Inc. Methods for non-invasive pre-natal ploidy calling
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11332785B2 (en) * 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US20190284623A1 (en) * 2010-05-18 2019-09-19 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
AU2011348100B2 (en) 2010-12-22 2016-08-25 Natera, Inc. Methods for non-invasive prenatal paternity testing
JP6153874B2 (ja) 2011-02-09 2017-06-28 ナテラ， インコーポレイテッド 非侵襲的出生前倍数性呼び出しのための方法
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
PL3004388T5 (pl) 2013-05-29 2023-10-09 Chronix Biomedical Wykrywanie i oznaczanie ilościowe pozakomórkowego dna dawcy w układzie krążenia biorców przeszczepów organów
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
PL3117012T5 (pl) 2014-03-14 2026-03-16 Caredx, Inc. Sposoby monitorowania terapii immunosupresyjnych u biorcy przeszczepu
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
RU2717641C2 (ru) 2014-04-21 2020-03-24 Натера, Инк. Обнаружение мутаций и плоидности в хромосомных сегментах
US20180173845A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
EP3164503B1 (en) 2014-07-03 2024-08-28 Agilent Technologies, Inc. Methods for non-invasive detection of transplant health or rejection
EP4428863A3 (en) 2015-05-11 2024-12-11 Natera, Inc. Methods and compositions for determining ploidy
CN106544407B (zh) * 2015-09-18 2019-11-08 广州华大基因医学检验所有限公司 确定受体cfDNA样本中供体来源cfDNA比例的方法
CN105483123B (zh) * 2015-11-23 2019-02-22 元码基因科技（北京）股份有限公司 遗传标记组合、个体基因身份证及其用途
JP7280044B2 (ja) 2016-04-15 2023-05-23 ナテラ， インコーポレイテッド 肺癌の検出方法
WO2018067517A1 (en) 2016-10-04 2018-04-12 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
US20190367972A1 (en) * 2016-11-02 2019-12-05 The Medical College Of Wisconsin, Inc. Methods for assessing risk using total and specific cell-free dna
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
CN106520982B (zh) * 2016-12-05 2019-11-08 中国人民解放军军事医学科学院放射与辐射医学研究所 一种用于身份鉴定的复合分型系统
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
CN107058562B (zh) * 2017-05-17 2018-04-10 成都仕康美生物科技有限公司 Snp位点的应用及其检测试剂盒
CN110945136A (zh) 2017-06-20 2020-03-31 威斯康星州立大学医学院 使用总无细胞dna评估移植并发症风险
US20210139983A1 (en) * 2017-06-20 2021-05-13 The Medical College Of Wisconsin, Inc. Transplant patient monitoring with cell-free dna
WO2019118926A1 (en) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Assessing graft suitability for transplantation
SG11202005474RA (en) * 2017-12-15 2020-07-29 Acrannolife Genomics Pvt Ltd A non-invasive method for monitoring transplanted organ status in organ-transplant recipients
EP3737773B1 (en) 2018-01-12 2023-04-12 Natera, Inc. Novel primers and uses thereof
CN107937571B (zh) * 2018-01-16 2021-12-07 良培基因生物科技（武汉）有限公司 一种基于信息snp集及其引物的核酸质谱亲权鉴定方法
EP3517629A1 (en) 2018-01-30 2019-07-31 Myway Genetics S.r.L. Use of cfdna fragments as biomarkers in patients after organ transplantation
WO2019161244A1 (en) 2018-02-15 2019-08-22 Natera, Inc. Methods for isolating nucleic acids with size selection
DK3781714T3 (da) 2018-04-14 2026-03-30 Natera Inc Fremgangsmåder til cancerpåvisning og -overvågning ved personlig påvisning af cirkulerende tumor-dna
CN112752852A (zh) * 2018-07-03 2021-05-04 纳特拉公司 用于检测供体来源的细胞游离dna的方法
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
EP3847280A1 (en) 2018-09-07 2021-07-14 Sequenom, Inc. Methods, and systems to detect transplant rejection
US20200109449A1 (en) * 2018-10-09 2020-04-09 Tai Diagnostics, Inc. Cell lysis assay for cell-free dna analysis
US20220073989A1 (en) * 2018-12-20 2022-03-10 The Regents Of The University Of California Optimizing Detection of Transplant Injury by Donor-Derived Cell-Free DNA
US20220093208A1 (en) * 2019-02-19 2022-03-24 Sequenom, Inc. Compositions, methods, and systems to detect hematopoietic stem cell transplantation status
US11931674B2 (en) 2019-04-04 2024-03-19 Natera, Inc. Materials and methods for processing blood samples
US12305235B2 (en) 2019-06-06 2025-05-20 Natera, Inc. Methods for detecting immune cell DNA and monitoring immune system
EP4106872B1 (en) * 2020-03-06 2026-07-15 Denovo Biopharma LLC Compositions and methods for assessing the efficacy of inhibitors of neurotransmitter transporters
US20210395835A1 (en) * 2020-06-19 2021-12-23 Caredx, Inc. Methods for monitoring allogeneic cells
CN113061666A (zh) * 2020-12-30 2021-07-02 中南大学湘雅二医院 肝移植后巨细胞病毒的检测方法、应用及系统
US20220356521A1 (en) * 2021-04-30 2022-11-10 Caredx, Inc. Methods for detecting, monitoring, and guiding treatment of allograft rejection using discriminating gene expression signatures
US20240279720A1 (en) * 2021-07-23 2024-08-22 Georgetown University Use of genetic and epigenetic markers to detect cell death
CA3227761A1 (en) * 2021-07-29 2023-02-02 Northwestern University Methods, systems, and compositions for diagnosing transplant rejection
CN118922560A (zh) * 2022-03-21 2024-11-08 凯尔迪克斯公司 用于在跨物种移植中非侵入性监测器官健康的方法
US20230338419A1 (en) * 2022-03-21 2023-10-26 The Trustees Of The University Of Pennsylvania Methods and apparatus for diagnosis and detection of cardiac allograft vasculopathy

Family Cites Families (158)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US6401267B1 (en) 1993-09-27 2002-06-11 Radoje Drmanac Methods and compositions for efficient nucleic acid sequencing
USRE39920E1 (en) * 1997-05-30 2007-11-13 Xenomics, Inc. Methods for detection of nucleic acid sequences in urine
US6132997A (en) 1999-05-28 2000-10-17 Agilent Technologies Method for linear mRNA amplification
US7403972B1 (en) 2002-04-24 2008-07-22 Ip Venture, Inc. Method and system for enhanced messaging
US20020197630A1 (en) 2001-04-12 2002-12-26 Knapp Michael R. Systems and methods for high throughput genetic analysis
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US6977162B2 (en) 2002-03-01 2005-12-20 Ravgen, Inc. Rapid analysis of variations in a genome
US7727720B2 (en) 2002-05-08 2010-06-01 Ravgen, Inc. Methods for detection of genetic disorders
US10229244B2 (en) 2002-11-11 2019-03-12 Affymetrix, Inc. Methods for identifying DNA copy number changes using hidden markov model based estimations
EP1689884A4 (en) 2003-10-08 2007-04-04 Univ Boston PROCESS FOR THE PRENATAL DIAGNOSIS OF CHROMOSOMAL ABNORMALITIES
US7149658B2 (en) 2004-02-02 2006-12-12 United Parcel Service Of America, Inc. Systems and methods for transporting a product using an environmental sensor
US8024128B2 (en) 2004-09-07 2011-09-20 Gene Security Network, Inc. System and method for improving clinical decisions by aggregating, validating and analysing genetic and phenotypic data
US7645575B2 (en) 2004-09-08 2010-01-12 Xdx, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
US20060228721A1 (en) 2005-04-12 2006-10-12 Leamon John H Methods for determining sequence variants using ultra-deep sequencing
US8532930B2 (en) 2005-11-26 2013-09-10 Natera, Inc. Method for determining the number of copies of a chromosome in the genome of a target individual using genetic data from genetically related individuals
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US20070027636A1 (en) 2005-07-29 2007-02-01 Matthew Rabinowitz System and method for using genetic, phentoypic and clinical data to make predictions for clinical or lifestyle decisions
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US8515679B2 (en) 2005-12-06 2013-08-20 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US20070178501A1 (en) 2005-12-06 2007-08-02 Matthew Rabinowitz System and method for integrating and validating genotypic, phenotypic and medical information into a database according to a standardized ontology
AU2007309726A1 (en) 2006-04-07 2008-05-02 Xdx, Inc. Steroid responsive nucleic acid expression and prediction of disease activity
WO2008021431A2 (en) 2006-08-14 2008-02-21 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
CA2668608A1 (en) 2006-11-08 2008-06-05 Aldagen, Inc. Methods for using aldhbr cells to supplement stem cell transplantation
US12054776B2 (en) 2007-07-23 2024-08-06 The Chinese University Of Hong Kong Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing
US9370689B2 (en) 2008-01-07 2016-06-21 The Quantum Group, Inc. System and methods for providing dynamic integrated wellness assessment
US20110033862A1 (en) 2008-02-19 2011-02-10 Gene Security Network, Inc. Methods for cell genotyping
US20110092763A1 (en) 2008-05-27 2011-04-21 Gene Security Network, Inc. Methods for Embryo Characterization and Comparison
US20160371432A1 (en) 2008-05-27 2016-12-22 Natera, Inc. Methods for allele calling and ploidy calling
ES2532153T3 (es) * 2008-07-18 2015-03-24 Trovagene, Inc. Métodos para la detección de secuencias de ácidos nucleicos "ultracortos" basados en PCR
CN104732118B (zh) 2008-08-04 2017-08-22 纳特拉公司 等位基因调用和倍性调用的方法
WO2010027870A2 (en) 2008-08-26 2010-03-11 Fluidigm Corporation Assay methods for increased throughput of samples and/or targets
EP2364368B1 (en) * 2008-11-07 2014-01-15 Sequenta, Inc. Methods of monitoring conditions by sequence analysis
EP3249053A1 (en) 2009-03-27 2017-11-29 Life Technologies Corporation Methods, compositions, and kits for detecting allelic variants
ES2640776T3 (es) 2009-09-30 2017-11-06 Natera, Inc. Métodos para denominar de forma no invasiva ploidía prenatal
DK2496720T3 (da) * 2009-11-06 2020-09-28 Univ Leland Stanford Junior Ikke-invasiv diagnose af transplantatafstødning i organ-transplanterede patienter
US20110173023A1 (en) 2010-01-12 2011-07-14 Gryphes Inc. Method and System for Managing Organ Transplant Transporation
US20140206552A1 (en) 2010-05-18 2014-07-24 Natera, Inc. Methods for preimplantation genetic diagnosis by sequencing
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US20130196862A1 (en) 2010-05-18 2013-08-01 Natera, Inc. Informatics Enhanced Analysis of Fetal Samples Subject to Maternal Contamination
US20220356526A1 (en) 2010-05-18 2022-11-10 Natera, Inc. Methods for simultaneous amplification of target loci
US20130123120A1 (en) 2010-05-18 2013-05-16 Natera, Inc. Highly Multiplex PCR Methods and Compositions
EP2854058A3 (en) 2010-05-18 2015-10-28 Natera, Inc. Methods for non-invasive pre-natal ploidy calling
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20120034603A1 (en) * 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
US20180344215A1 (en) 2015-11-24 2018-12-06 Dacadoo Ag Automated health data acquisition, processing and communication system and method
AU2011348100B2 (en) 2010-12-22 2016-08-25 Natera, Inc. Methods for non-invasive prenatal paternity testing
US10131947B2 (en) * 2011-01-25 2018-11-20 Ariosa Diagnostics, Inc. Noninvasive detection of fetal aneuploidy in egg donor pregnancies
CN102618626B (zh) * 2011-01-30 2014-05-14 杭州优思达生物技术有限公司 一种快速单核苷酸多态性的检测方法及试剂盒
JP6153874B2 (ja) 2011-02-09 2017-06-28 ナテラ， インコーポレイテッド 非侵襲的出生前倍数性呼び出しのための方法
US20130024127A1 (en) 2011-07-19 2013-01-24 John Stuelpnagel Determination of source contributions using binomial probability calculations
CA3069089A1 (en) 2011-09-22 2013-03-28 Lineage Biosciences, Inc. Compositions and methods for analyzing heterogeneous samples
AU2012321053B2 (en) 2011-10-07 2018-04-19 Murdoch Childrens Research Institute Diagnostic assay for tissue transplantation status
US8977373B2 (en) 2011-12-28 2015-03-10 Caterpillar Inc. Systems and methods for extending physical sensor range using virtual sensors
CN103374518B (zh) * 2012-04-12 2018-03-27 维里纳塔健康公司 拷贝数变异的检测和分类
US10385396B2 (en) 2012-04-19 2019-08-20 The Medical College Of Wisconsin, Inc. Highly sensitive surveillance using detection of cell free DNA
US20150154352A1 (en) 2012-06-21 2015-06-04 Gigagen, Inc. System and Methods for Genetic Analysis of Mixed Cell Populations
US20150203916A1 (en) 2012-06-27 2015-07-23 Music Foundation For Research Development Plasma analytes predict diagnosis and prognosis of thoracic aortic aneurysm
US20140051585A1 (en) 2012-08-15 2014-02-20 Natera, Inc. Methods and compositions for reducing genetic library contamination
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
US20140065621A1 (en) 2012-09-04 2014-03-06 Natera, Inc. Methods for increasing fetal fraction in maternal blood
US9852266B2 (en) 2012-09-21 2017-12-26 Md Revolution, Inc. Interactive graphical user interfaces for implementing personalized health and wellness programs
WO2014074501A1 (en) 2012-11-06 2014-05-15 Quest Diagnostics Investments Incorporated Molecular markers for diagnosis of acute cellular rejection and acute tubular necrosis
WO2014116729A2 (en) 2013-01-22 2014-07-31 The Board Of Trustees Of The Leland Stanford Junior University Haplotying of hla loci with ultra-deep shotgun sequencing
WO2014180910A1 (en) 2013-05-09 2014-11-13 Roche Diagnostics Gmbh Method of determining the fraction of fetal dna in maternal blood using hla markers
PL3004388T5 (pl) 2013-05-29 2023-10-09 Chronix Biomedical Wykrywanie i oznaczanie ilościowe pozakomórkowego dna dawcy w układzie krążenia biorców przeszczepów organów
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
US10262755B2 (en) 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
WO2015048535A1 (en) 2013-09-27 2015-04-02 Natera, Inc. Prenatal diagnostic resting standards
WO2015069933A1 (en) 2013-11-06 2015-05-14 The Board Of Trustees Of The Leland Stanford Junior University Circulating cell-free dna for diagnosis of transplant rejection
WO2015085350A1 (en) 2013-12-10 2015-06-18 Conexio Genomics Pty Ltd Methods and probes for identifying gene alleles
US9982301B2 (en) 2014-01-07 2018-05-29 Cornell University Urine mRNA profile and acute dysfunction of kidney allograft
PL3117012T5 (pl) 2014-03-14 2026-03-16 Caredx, Inc. Sposoby monitorowania terapii immunosupresyjnych u biorcy przeszczepu
US20250388965A1 (en) 2014-03-14 2025-12-25 Caredx, Inc. Methods and systems for processing cell-free samples
RU2717641C2 (ru) 2014-04-21 2020-03-24 Натера, Инк. Обнаружение мутаций и плоидности в хромосомных сегментах
US20180173845A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
AU2015296029B2 (en) 2014-08-01 2022-01-27 Dovetail Genomics, Llc Tagging nucleic acids for sequence assembly
AU2016255573A1 (en) 2015-04-30 2017-12-21 The Medical College Of Wisconsin, Inc. Multiplexed optimized mismatch amplification (MOMA)-real time PCR for assessing cell-free DNA
EP4428863A3 (en) 2015-05-11 2024-12-11 Natera, Inc. Methods and compositions for determining ploidy
EP3307912B1 (en) 2015-06-15 2021-09-15 Murdoch Childrens Research Institute Method of measuring chimerism
US20160371428A1 (en) 2015-06-19 2016-12-22 Natera, Inc. Systems and methods for determining aneuploidy risk using sample fetal fraction
US9648446B2 (en) 2015-09-22 2017-05-09 Veniam, Inc. Systems and methods for shipping management in a network of moving things
HUE044940T2 (hu) 2016-01-27 2019-11-28 Devyser Holding Ab Kívánt nukleinsavrégiók szelektív amplifikálása egy célbavett szekvenciában
JP7280044B2 (ja) 2016-04-15 2023-05-23 ナテラ， インコーポレイテッド 肺癌の検出方法
CA3022572A1 (en) 2016-04-29 2017-11-02 The Medical College Of Wisconsin, Inc. Multiplexed optimized mismatch amplification (moma)-target number
WO2018000031A1 (en) 2016-06-27 2018-01-04 Olivia Newton-John Cancer Research Institute Use of cell free dna as a measure of organ health following transplantation
CA3025956A1 (en) 2016-07-01 2018-01-04 Natera, Inc. Compositions and methods for detection of nucleic acid mutations
US10602964B2 (en) 2016-08-17 2020-03-31 Koninklijke Philips N.V. Location, activity, and health compliance monitoring using multidimensional context analysis
WO2018067517A1 (en) 2016-10-04 2018-04-12 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
US20190367972A1 (en) 2016-11-02 2019-12-05 The Medical College Of Wisconsin, Inc. Methods for assessing risk using total and specific cell-free dna
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
CA3049139A1 (en) 2017-02-21 2018-08-30 Natera, Inc. Compositions, methods, and kits for isolating nucleic acids
JP6970205B2 (ja) * 2017-03-08 2021-11-24 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Ｄｎａおよびｒｎａの同時濃縮を含むプライマー伸長標的濃縮およびそれに対する向上
EP3607088A4 (en) 2017-04-04 2020-12-23 The Board of Trustees of the Leland Stanford Junior University QUANTIFICATION OF CIRCULATING ACELLULAR DNA DERIVED FROM TRANSPLANT IN THE ABSENCE OF A DONOR GENOTYPE
CN111094593A (zh) 2017-06-20 2020-05-01 威斯康星州立大学医学院 使用供体特异性无细胞dna来评估移植对象中的病症
CN110945136A (zh) 2017-06-20 2020-03-31 威斯康星州立大学医学院 使用总无细胞dna评估移植并发症风险
US11990208B2 (en) 2017-06-20 2024-05-21 Illumina, Inc. Methods for accurate computational decomposition of DNA mixtures from contributors of unknown genotypes
US20210139983A1 (en) 2017-06-20 2021-05-13 The Medical College Of Wisconsin, Inc. Transplant patient monitoring with cell-free dna
WO2018236911A1 (en) 2017-06-20 2018-12-27 Illumina, Inc. Methods and systems for decomposition and quantification of dna mixtures from multiple contributors of known or unknown genotypes
CN111886015B (zh) 2017-10-31 2024-04-26 艾洛基治疗公司 用于同种异体嵌合抗原受体t细胞的给药的方法和组合物
WO2019118926A1 (en) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Assessing graft suitability for transplantation
SG11202005474RA (en) 2017-12-15 2020-07-29 Acrannolife Genomics Pvt Ltd A non-invasive method for monitoring transplanted organ status in organ-transplant recipients
US11961033B2 (en) 2018-01-05 2024-04-16 Convey, Llc System and method for dynamically scheduling API-based shipment updates across carriers
EP3737773B1 (en) 2018-01-12 2023-04-12 Natera, Inc. Novel primers and uses thereof
EP3740173A4 (en) 2018-01-19 2022-02-09 University of Maryland, Baltimore TECHNIQUES FOR HANDLING A HUMAN ORGAN DURING TRANSPORT
EP3517629A1 (en) 2018-01-30 2019-07-31 Myway Genetics S.r.L. Use of cfdna fragments as biomarkers in patients after organ transplantation
WO2019161244A1 (en) 2018-02-15 2019-08-22 Natera, Inc. Methods for isolating nucleic acids with size selection
WO2019178143A1 (en) 2018-03-12 2019-09-19 The Regents Of The University Of California Assessing transplant rejection status by analysis of t-cell receptor subunit repertoire diversity
DK3781714T3 (da) 2018-04-14 2026-03-30 Natera Inc Fremgangsmåder til cancerpåvisning og -overvågning ved personlig påvisning af cirkulerende tumor-dna
EP4194564A1 (en) 2018-05-10 2023-06-14 The Scripps Research Institute Genome-wide classifiers for detection of subacute transplant rejection and other transplant conditions
WO2019241349A1 (en) 2018-06-12 2019-12-19 Natera, Inc. Methods and systems for calling mutations
CN112752852A (zh) * 2018-07-03 2021-05-04 纳特拉公司 用于检测供体来源的细胞游离dna的方法
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
WO2020018522A1 (en) 2018-07-17 2020-01-23 Natera, Inc. Methods and systems for calling ploidy states using a neural network
US10402774B1 (en) 2018-07-25 2019-09-03 Capital One Services, LLP Intelligence platform for automated retrieval or protection of a package or a person by an unmanned vehicle (UV)
EP3847280A1 (en) * 2018-09-07 2021-07-14 Sequenom, Inc. Methods, and systems to detect transplant rejection
US20200109449A1 (en) 2018-10-09 2020-04-09 Tai Diagnostics, Inc. Cell lysis assay for cell-free dna analysis
WO2020118046A1 (en) 2018-12-05 2020-06-11 William Marsh Rice University Quantifying foreign dna in low-volume blood samples using snp profiling
EP3899033A4 (en) 2018-12-17 2022-10-19 The Medical College of Wisconsin, Inc. Assessing risk with total cell-free dna
EP4617383A3 (en) 2018-12-17 2025-12-24 Natera, Inc. Methods for analysis of circulating cells
US20220073989A1 (en) * 2018-12-20 2022-03-10 The Regents Of The University Of California Optimizing Detection of Transplant Injury by Donor-Derived Cell-Free DNA
US20220081715A1 (en) 2019-01-17 2022-03-17 Katholieke Universiteit Leuven mRNA-BASED BIOMARKERS FOR ANTIBODY-MEDIATED TRANSPLANT REJECTION
US20220093208A1 (en) 2019-02-19 2022-03-24 Sequenom, Inc. Compositions, methods, and systems to detect hematopoietic stem cell transplantation status
EP3712898A1 (en) 2019-03-21 2020-09-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Method of predicting whether a kidney transplant recipient is at risk of having allograft loss
WO2020206290A1 (en) 2019-04-03 2020-10-08 The Medical College Of Wisconsin, Inc. Methods for assessing risk using total cell-free dna
WO2020206292A2 (en) 2019-04-03 2020-10-08 The Medical College Of Wisconsin, Inc. Assessing conditions in transplant subjects using donor-specific cell-free dna
CA3135853A1 (en) 2019-04-03 2020-10-08 The Medical College Of Wisconsin, Inc. Transplant patient monitoring with cell-free dna
US11931674B2 (en) 2019-04-04 2024-03-19 Natera, Inc. Materials and methods for processing blood samples
EP3956466A1 (en) 2019-04-15 2022-02-23 Natera, Inc. Improved liquid biopsy using size selection
US12305235B2 (en) 2019-06-06 2025-05-20 Natera, Inc. Methods for detecting immune cell DNA and monitoring immune system
WO2021021657A1 (en) 2019-07-29 2021-02-04 University Of Miami System and method for ai-based eye condition determinations
US20220340963A1 (en) 2019-09-20 2022-10-27 Natera, Inc. Methods for assessing graft suitability for transplantation
US20220392568A1 (en) 2019-10-31 2022-12-08 Caredx, Inc. Method for identifying transplant donors for a transplant recipient
AU2020378435B2 (en) 2019-11-06 2026-07-30 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for analyzing nucleic acid molecules
GB2612447B (en) 2020-04-24 2025-08-13 Univ Cornell Methods for detecting tissue damage, graft versus host disease, and infections using cell-free DNA profiling
US20230203573A1 (en) 2020-05-29 2023-06-29 Natera, Inc. Methods for detection of donor-derived cell-free dna
US11700847B2 (en) 2020-06-06 2023-07-18 MediGO, Inc. Systems and methods for vital asset transport
US20210395835A1 (en) 2020-06-19 2021-12-23 Caredx, Inc. Methods for monitoring allogeneic cells
WO2022015676A1 (en) 2020-07-13 2022-01-20 The Medical College Of Wisconsin, Inc. Methods for making treatment management decisions in transplant subjects and assessing transplant risks with threshold values
WO2022035519A1 (en) 2020-08-14 2022-02-17 Caredx, Inc. A system and methods for determining scores indicative of a transplant recipient's activities and behaviors
EP4298248A1 (en) 2021-02-25 2024-01-03 Natera, Inc. Methods for detection of donor-derived cell-free dna in transplant recipients of multiple organs
AU2022261868A1 (en) 2021-04-22 2023-10-26 Natera, Inc. Methods for determining velocity of tumor growth
EP4330425A4 (en) 2021-04-29 2025-03-05 The Medical College of Wisconsin, Inc. METHODS FOR ASSESSING CELL OR TISSUE INJURY USING MITOCHONDRIAL AND/OR NUCLEAR CELL-FREE DNA
US20220356521A1 (en) 2021-04-30 2022-11-10 Caredx, Inc. Methods for detecting, monitoring, and guiding treatment of allograft rejection using discriminating gene expression signatures
EP4402289B1 (en) 2021-09-16 2026-04-01 Northwestern University Methods of using donor-derived cell-free dna to distinguish acute rejection and other conditions in liver transplant recipients
CN118804985A (zh) 2021-12-22 2024-10-18 广州医科大学附属第一医院（广州呼吸中心） 用于监测供体dna分数的方法
CN118922560A (zh) 2022-03-21 2024-11-08 凯尔迪克斯公司 用于在跨物种移植中非侵入性监测器官健康的方法
CA3249433A1 (en) 2022-04-29 2023-11-02 Caredx, Inc. SYSTEMS AND METHODS FOR CLASSIFYING THE STATE OF A GRAFTING
CN119301270A (zh) 2022-06-03 2025-01-10 凯尔迪克斯公司 用于预测移植排斥的系统和方法
JP2025006152A (ja) 2023-06-29 2025-01-17 キヤノン株式会社 光電変換装置、機器、および信号処理方法

Also Published As

Publication number Publication date
AU2021204489A1 (en) 2021-07-29
AU2023208145A1 (en) 2023-08-17
US20230407393A1 (en) 2023-12-21
CA2970916A1 (en) 2015-09-17
US20260132462A1 (en) 2026-05-14
US20230407396A1 (en) 2023-12-21
SI3117012T2 (sl) 2026-04-30
AU2021204489B2 (en) 2023-04-27
US20230399694A1 (en) 2023-12-14
BR112016021038A2 (pt) 2017-08-15
ES2726650T5 (en) 2026-04-14
US20230399696A1 (en) 2023-12-14
PL3117012T3 (pl) 2019-08-30
FI3117012T4 (fi) 2026-02-25
CA2970916C (en) 2025-02-04
DK3117012T3 (da) 2019-05-13
US12404547B1 (en) 2025-09-02
US11767559B2 (en) 2023-09-26
US20250354207A1 (en) 2025-11-20
CN106536752B (zh) 2021-08-06
SI3117012T1 (sl) 2019-07-31
US20160145682A1 (en) 2016-05-26
US12644153B2 (en) 2026-06-02
HRP20190759T1 (hr) 2019-06-14
PT3117012T (pt) 2019-05-30
US20230407392A1 (en) 2023-12-21
WO2015138997A1 (en) 2015-09-17
US20230407394A1 (en) 2023-12-21
ES2726650T3 (es) 2019-10-08
CN106536752A (zh) 2017-03-22
US20230399695A1 (en) 2023-12-14
EP3117012A1 (en) 2017-01-18
AU2015229083B2 (en) 2021-06-17
AU2015229083A1 (en) 2016-09-08
US20230407395A1 (en) 2023-12-21
EP3117012B1 (en) 2019-02-20
AU2023208145B2 (en) 2025-08-21
BR112016021038B1 (pt) 2023-12-12
TR201907106T4 (tr) 2019-06-21
HRP20190759T4 (hr) 2026-05-08
EP3117012B2 (en) 2025-11-26
CN113528645A (zh) 2021-10-22
EP3117012A4 (en) 2017-08-30
DK3117012T4 (da) 2026-02-09
HUE043288T2 (hu) 2019-08-28

Similar Documents

Publication Publication Date Title
IL276593B (en) Improved methods for producing adoptive cell therapies
HUE043288T2 (hu) Eljárások immunszuppresszív terápiák monitorozására transzplantátum recipiensben
ZA201700241B (en) Mnk inhibitors and methods related thereto
IL251045B (en) Macropinocytosing human anti-cd46 antibodies and targeted cancer therapeutics
PL3348156T3 (pl) System e-papierosa i metoda
SI3172567T1 (sl) Postopki in kompleti za nadzor membranske nefropatije
EP3191826C0 (en) SYSTEM AND METHOD FOR MEASURING DENSITY
IL249384A0 (en) Methods for producing cells using perfusate and their use
EP2998732C0 (en) ANALYSIS PROCESS
IL247840B (en) Sildenafil solutions and methods for their preparation and use
GB201417372D0 (en) Methods and kits
PL2908560T3 (pl) Sposób i układ odwzorowania
IL233451A0 (en) Charging system and method
TH1501007310A (th) ภาชนะเพาะเลี้ยงและวิธีเพาะเลี้ยง
TH1501006896A (th) อุปกรณ์และวิธีการพิสูจน์ตัวจริงด้วยตนเอง
TH1601002248A (th) องค์ประกอบฆ่าศัตรูพืชและสัตว์และวิธีที่เกี่ยวข้อง
TH1601002244A (th) องค์ประกอบฆ่าศัตรูพืชและสัตว์และวิธีที่เกี่ยวข้อง
TH1601002246A (th) องค์ประกอบฆ่าศัตรูพืชและสัตว์และวิธีที่เกี่ยวข้อง
TH1601000720A (th) วิธีการและระบบสำหรับตรวจสังเกตการนำส่ง
GB201415151D0 (en) Photoacoustic cell system and method